Based on the strength of the randomized study, the panel recommends voriconazole for primary treatment of these very uncommon manifestations of invasive aspergillosis (B-III).

• 在随机研究的力度的基础上，专家组推荐伏立康唑作为这些少见部位侵袭性曲菌病的用药首选。